Find clinical trials for Triple Negative Breast Cancer in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near New Haven, CT, USA:
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative b ...
Phase 2
Stamford, Connecticut, United States and 9 other locations
the feasibility of 1 year of adjuvant enzalutamide, an androgen receptor (AR) antagonist for the treatment of patients with early stage, AR(+) triple...
Phase 2
Hartford, Connecticut, United States and 11 other locations
maximum tolerated dose (MTD) of OTS167 administered via oral capsule (PO) to patients with relapsed/refractory locally advanced or metastatic breast...
Phase 1
Norwalk, Connecticut, United States and 3 other locations
a study drug called Rucaparib, administered in combination with the type of radiation therapy that is usually given to women with your form of breast...
Phase 1
Norwalk, Connecticut, United States and 7 other locations
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...
Phase 1, Phase 2
Norwalk, Connecticut, United States and 49 other locations
This research study is studying a drug called Carboplatin with or without another study drug, Nivolumab as a possible treatment for triple-n ...
Phase 2
Stamford, Connecticut, United States and 9 other locations
before the standard surgical procedure, to treat TNBC or HR+ HER2- breast cancers. The study drugs could shrink cancer, bu...
Phase 2
Commack, New York, United States and 6 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Danbury, Connecticut, United States and 165 other locations
The researchers are doing this study to find out whether the study drug, SDX-7320, when combined with the standard chemotherapy eribulin, is an effec...
Phase 2
Commack, New York, United States and 7 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
New Haven, Connecticut, United States and 228 other locations
Clinical trials
Research sites
Resources
Legal